3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
2
Urothelial Cancer
2
Rhabdoid Tumor
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Central Nervous System Neoplasms
2
Xanthogranuloma, Juvenile
1
Urinary Bladder Neoplasms
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Osteosarcoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Multiple Myeloma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Histiocytic Sarcoma
1
Familial ependymoma
1
Carcinoma, Transitional Cell
1
Breast Neoplasms
1
Advanced Solid Tumor
1
Interventions
Paclitaxel
6
Radiotherapy
2
Pemetrexed
2
Carboplatin
2
Brachytherapy
2
tucatinib
1
seribantumab
1
osimertinib
1
gedatolisib
1
fosaprepitant
1
fluciclovine F-18
1
cobimetinib
1
atezolizumab
1
alovudine
1
Trastuzumab
1
Therapeutics
1
TP protocol
1
Saline Solution
1
Radiation
1
Protons
1
Palliative Care
1
Nivolumab
1
Letrozole
1
Immunoglobulin G
1
Imatinib Mesylate
1
Ifosfamide
1
Gemcitabine
1
Fulvestrant
1
FANG vaccine
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uterine Neoplasms
×
erdafitinib
×
Clear all
No trials found.